Showing results (41-50 of 281) with videos related to
Sort By:
Pageof 29
European Journal of Cancer & Clinical Oncology|September 1, 1988
Therapeutic efficacy of danazol in myelodysplastic syndromesB Marini, R Bassan, T BarbuiBlood|April 16, 1998
Differential effects of anti-beta2-glycoprotein I and antiprothrombin antibodies on the anticoagulant activity of activated protein CM Galli, L Ruggeri, T BarbuiAmerican Journal of Hematology|April 1, 1985
Interaction between a serum factor and T lymphocytes in Gaucher diseaseR Bassan, A Montanelli, T BarbuiHematology (Amsterdam, Netherlands)|July 14, 2016
Antiphospholipid Antibodies and Associated Clinical ManifestationsM Galli, G Finazzi, T BarbuiThrombosis and Haemostasis|July 1, 1997
Antiphospholipid antibodies: predictive value of laboratory testsM Galli, G Finazzi, T BarbuiLeukemia & Lymphoma|May 26, 1999
Cellular uptake and antiproliferative effects of therapeutic concentrations of idarubicin or daunorubicin and their alcohol metabolites, with or without cyclosporin A, in MDR1+ human leukemic cellsB Chiodini, R Bassan, T BarbuiThrombosis and Haemostasis|June 30, 1981
Platelet activation in myeloproliferative disordersS Cortelazzo, P Viero, T BarbuiBollettino Dell'Istituto Sieroterapico Milanese|January 1, 1986
[Emerging pathologies and correlates of drug abuse in 2 therapeutic communities in Bergamo]L Robba, M L Carissoni, A Goglio, et al.Hematology (Amsterdam, Netherlands)|July 14, 2016
The Management of Essential ThrombocythaemiaT Barbui, G Finazzi, T C PearsonBritish Journal of Haematology|September 21, 2000
Second malignancies in patients with essential thrombocythaemia treated with busulphan and hydroxyurea: long-term follow-up of a randomized clinical trialG Finazzi, M Ruggeri, F Rodeghiero, et al.Pageof 29